Neurotransmitter Panel
- $2,574.71
- $712
- Save: 72.35%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: AChR Antibody, Muscle nicotinic Acetylcholine Receptor (AChR) Binding Antibody, Myasthenia Gravis Antibodies
Acetylcholine Receptor
Also known as: Dopamine Urine
Dopamine, 24 Hr Urine
Total Volume
Also known as: Glutamic Acid Decarboxylase65 Antibody
Glutamic Acid
GLUTAMIC ACID
Also known as: Norepinephrine Plasma
Norepinephrine, Plasma
Also known as: 5-HT, Serum, 5-Hydroxy Tryptamine, Serum, Serotonin Serum
Serotonin, Serum
The Neurotransmitter Panel panel contains 5 tests with 7 biomarkers .
Neurotransmitter Panel
Comprehensive screening for neuromuscular, mood, and autonomic disorders
Why test neurotransmitters?
Neurotransmitters and their antibodies orchestrate every signal between brain, nerves, and muscles. Imbalances or immune attacks can trigger muscle weakness, tremors, chronic anxiety, unexplained hypertension, or sudden mood swings. This panel pulls together five cornerstone markers so your clinician can detect disease early, confirm a diagnosis, track therapy, and fine-tune treatment—all from a single visit.
What’s included & how each marker helps
| Test | What it Measures | Key Conditions Detected / Monitored |
|---|---|---|
| Acetylcholine Receptor (AChR) Binding Antibody | Autoantibodies that block acetylcholine receptors at the neuromuscular junction | Myasthenia gravis (85–90 % of generalized cases), congenital myasthenic syndromes; rising titers flag flares, falling titers confirm treatment success |
| Dopamine, Urine (24 h) | Catecholamine metabolite excreted in urine | Pheochromocytoma/paraganglioma, neuroblastoma; low or fluctuating levels seen in Parkinson’s disease, dystonia, ADHD, certain depressive disorders |
| Glutamic Acid Decarboxylase-65 (GAD-65) Antibody | Autoantibodies against the GAD enzyme that produces GABA | Stiff-person syndrome, autoimmune epilepsy, cerebellar ataxia, latent autoimmune diabetes in adults (LADA); titers track disease burden |
| Norepinephrine, Plasma | Primary sympathetic “fight-or-flight” neurotransmitter | Pheochromocytoma, orthostatic hypotension, postural orthostatic tachycardia syndrome (POTS), autonomic failure, chronic stress-related hypertension |
| Serotonin, Serum | Key mood and gut modulator synthesized from tryptophan | Carcinoid tumors (marked elevations), serotonin syndrome, migraines, IBS; low levels correlate with major depression, anxiety, fibromyalgia |
Who should consider this panel?
-
Persistent muscle fatigue, drooping eyelids, or double vision
-
Episodic high blood pressure, palpitations, or excessive sweating
-
Treatment-resistant depression, chronic anxiety, or sudden mood changes
-
Recurrent migraines, GI flushing, or unexplained diarrhea
-
Family history of myasthenia gravis, carcinoid, or catecholamine-secreting tumors
-
Clinicians tracking response to immunotherapy or neurologic medications
How results guide care
-
Early detection: Highly specific antibodies (AChR, GAD65) confirm autoimmune disorders before irreversible damage.
-
Precision therapy: Dopamine and norepinephrine levels steer medication choices for movement or autonomic disorders.
-
Monitoring: Serial serotonin, catecholamines, and antibody titers reveal flare-ups, remission, or tumor recurrence.
Fast, convenient testing
-
Samples: One blood draw (AChR Ab, GAD65 Ab, norepinephrine, serotonin) + a 24-hour urine collection kit (dopamine)
-
Turnaround: Results in 2–4 business days for most markers
-
Actionable report: Plain-language explanations plus physician-ready specifics
Take charge of your neurologic and metabolic health—order the Neurotransmitter Panel today and give your care team the data they need to keep your nerves, muscles, mood, and blood pressure in balance.